PINPOINT

Horizon Discovery Limited

Application Filed: 2020-01-21
Trademark Application Details
Trademark Logo PINPOINT

Mark For: PINPOINT® trademark registration is intended to cover the categories of biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and commercial use; Diagnostic preparations and materials generated by the use of base editing components; chemical preparation for use in DNA analysis (medical); DNA, RNA and parts thereof; DNA extracts; DNA reference standards; DNA reference libraries being collections of DNA and gene sequences; gene editing enzymes; protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical and commercial use; all the aforesaid goods being medical preparations; Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services; Custom cell-line engineering services; base-editing services; gene engineering services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines; creating libraries or collections of normal and mutated genes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies.

Status

2020-01-24 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88768179
Registration Number6325211
Mark Literal ElementsPINPOINT
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationNEW APPLICATION PROCESSING 2020-01-24
Basis44(d)
Class StatusACTIVE
Primary US Classes
  • 001: Raw or Partly Prepared Materials
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 010: Fertilizers
  • 026: Measuring and Scientific Appliances
  • 046: Foods and Ingredients of Foods
Primary International Class
  • 001 - Primary Class
  • (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledYes
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeRebecca Liebowitz
Attorney NameRebecca Liebowitz
Attorney Docket Number60895-516779

Timeline

2020-01-21Application Filed
2020-01-24Location: NEW APPLICATION PROCESSING
2020-01-24Status: Live/Pending
2020-01-24Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2020-01-24Transaction Date
2021-04-20Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Horizon Discovery Limited
Address8100 Cambridge Research Park, Waterbeach Cambridge UNITED KINGDOM CB259TL
Legal Entity TypePrivate Limited Company
Legal Entity StateUNITED KINGDOM

Attorney of Record

REBECCA LIEBOWITZ
VENABLE LLP
P.O. BOX 34385
WASHINGTON, DC 20043-9998

Good, Services, and Codes

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:9
U.S. Codes:021,023,026,036,038
International Codes:40
U.S. Codes:100,103,106
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0011Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and commercial use; Diagnostic preparations and materials generated by the use of base editing components; chemical preparation for use in DNA analysis (medical); DNA, RNA and parts thereof; DNA extracts; DNA reference standards; DNA reference libraries being collections of DNA and gene sequences; gene editing enzymes; protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical and commercial use; all the aforesaid goods being medical preparations; Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services; Custom cell-line engineering services; base-editing services; gene engineering services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines; creating libraries or collections of normal and mutated genes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies
GS0011Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2021-04-20
PUBLISHED FOR OPPOSITION2021-02-02
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-02-02
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-01-13
APPROVED FOR PUB - PRINCIPAL REGISTER2020-12-28
TEAS/EMAIL CORRESPONDENCE ENTERED2020-12-2688889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-12-26
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-12-2688889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-09-296325
NON-FINAL ACTION WRITTEN2020-09-2993058
NON-FINAL ACTION E-MAILED2020-09-296325
TEAS/EMAIL CORRESPONDENCE ENTERED2020-09-2888889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-09-26
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-09-2688889
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-06-04
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-06-04
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-06-04
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-04-096325
NON-FINAL ACTION WRITTEN2020-04-0993058
NON-FINAL ACTION E-MAILED2020-04-096325
ASSIGNED TO EXAMINER2020-04-0893058
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED2020-03-3066213
ASSIGNED TO LIE2020-03-2666213
TEAS VOLUNTARY AMENDMENT RECEIVED2020-03-20
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-01-25
NEW APPLICATION ENTERED IN TRAM2020-01-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed